Transforming Fertility Journeys: Gaudium IVF’s AI-Powered Breakthrough with SiD and ERICA
Published: 13 Apr 2026
Author: Deepa Pandey
Gaudium IVF, a prominent leader in India's fertility healthcare sector, has launched AI-driven infertility treatment, representing a significant advancement for the organization. This initiative follows closely on the heels of Gaudium IVF becoming India's first publicly listed IVF chain, further solidifying its status as an innovator in reproductive medicine. The new program incorporates advanced AI-based embryology systems into standard fertility treatments, intending to enhance precision, improve clinical outcomes, and boost patient confidence throughout the in vitro fertilization (IVF) process.
According to Precedence Research, the AI-Powered Embryo Selection Market was valued at USD 320.00 million in 2025 and is projected to grow from USD 379.20 million in 2026 to approximately USD 1,747.16 million by 2035, expanding at a CAGR of 18.50% from 2026 to 2035, driven by increasing integration of AI in IVF treatments.
AI’s Role in the Future of IVF
Gaudium IVF has integrated two AI technologies into its clinical workflow:
- SiD (Sperm Identification Device)
- ERICA (Embryo Ranking Intelligent Classification Assistant)
These systems support decision-making in key stages of IVF, including sperm selection and embryo ranking.
The launch was inaugurated by Union Minister for Road Transport and Highways, Shri Nitin Jairam Gadkari, who highlighted the growing role of technology and innovation in India’s development.
Gaudium IVF has formed a partnership with IVF 2.0, a UK-based organization specializing in embryology innovation, founded by Dr. Jacques Cohen and Dr. Alejandro Chave, to introduce reproductive technologies in India. This collaboration aims to bring AI-based embryology to the country, to improve fertility outcomes, enhance precision, and bolster patient confidence in IVF treatments.
SiD and ERICA: Elevating IVF Success
The newly developed AI fertility tools enhance two critical stages of in vitro fertilization (IVF). The Sperm Identification Device (SiD) evaluates sperm motility and biological characteristics to identify the most viable sperm, improving blastocyst quality and fertilization rates. The Embryo Ranking Intelligent Classification Assistant (ERICA) assesses embryos from static images to select those with the greatest implantation potential.
Together, SiD and ERICA are non-invasive AI tools that support more precise embryology decisions and reduce human variability. Initial findings suggest they may improve fertilization and blastocyst development, lower the need for repeat IVF cycles, and ease emotional, physical, and financial burdens.
A recent report by Precedence Research highlights that the AI-powered embryo selection market is benefiting from the increasing rate of infertility.